Topamax® Birth Defects
January 10th, 2017|
The pharmaceutical industry is unique in that the products they manufacturer often have an extended life beyond their initial intent. That’s certainly the case for Topamax®. Originally designed to treat epilepsy and migraines, Topamax was approved by the FDA in 2012 to treat obesity and induce weight loss. In addition, doctors have prescribed Topamax for a number of off-label uses, including smoking cessation, as well as treatment of cluster headaches and alcoholism.
However versatile the medication, it still comes with some dangerous side effects. Babies exposed to Topamax while in the womb have an increased risk of developing a cleft palette, cleft lip, and other congenital malformations. If left untreated, these conditions have profoundly negative consequences on a child’s mental and emotional wellbeing, including low self-esteem and social anxiety.
If your child was born with a cleft palette or cleft lip after you were prescribed Topamax, give our experienced drug injury lawyers a call for your free claim evaluation. You may be entitled to significant compensation for your child’s condition, but you need to act quickly to file an injury claim against the drug manufacturer. Contact our Topamax injury lawyers today and we’ll get started on your case immediately.